EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+15.98%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$142M
AUM Growth
+$142M
(+12%)
Cap. Flow
-$54.9K
Cap. Flow
% of AUM
-0.04%
Top 10 Holdings %
Top 10 Hldgs %
49.55%
Holding
52
New
6
Increased
14
Reduced
22
Closed
7
Top Buys
| 1 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
$2.8M |
| 2 |
THOR
Synthorx, Inc. Common Stock
THOR
|
$2.44M |
| 3 |
argenx
ARGX
|
$2.35M |
| 4 |
ATNX
Athenex, Inc. Common Stock
ATNX
|
$2.31M |
| 5 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$2.14M |
Top Sells
| 1 |
Alnylam Pharmaceuticals
ALNY
|
$2.33M |
| 2 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$1.98M |
| 3 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$1.84M |
| 4 |
IMMU
Immunomedics Inc
IMMU
|
$1.76M |
| 5 |
Armstrong World Industries
AWI
|
$1.66M |
Sector Composition
| 1 | Healthcare | 52.79% |
| 2 | Financials | 31.36% |
| 3 | Consumer Discretionary | 8.42% |
| 4 | Industrials | 2.47% |
| 5 | Technology | 1.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Berkshire Hathaway Class A
BRK.A
$1.09T
| $35.2M | 24.77% | 117 | – | – |
|
2
JD.com
JD
$44.1B
| $12M | 8.42% | 397,528 -50 | -0% | -$1.51K |
|
3
Ascendis Pharma
ASND
$11.8B
| $3.82M | 2.69% | 32,477 -6,740 | -17% | -$793K |
|
4
Amicus Therapeutics
FOLD
$2.34B
| $2.84M | 2% | 208,854 -9,020 | -4% | -$123K |
|
|
AMRN
5
Amarin Corp
AMRN
$311M
| $2.8M | 1.97% | 135,058 +5,665 | +4% | +$118K |
|
|
ORTX
6
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $2.8M | 1.97% | +156,401 | New | +$2.8M |
|
|
ZGNX
7
DELISTED
Zogenix, Inc.
ZGNX
| $2.79M | 1.96% | 50,758 -7,064 | -12% | -$389K |
|
8
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.75M | 1.94% | 102,586 -20,029 | -16% | -$538K |
|
9
Solid Biosciences
SLDB
$427M
| $2.75M | 1.93% | 298,887 +230,173 | +335% | +$2.12M |
|
10
InflaRx
IFRX
$108M
| $2.72M | 1.91% | 71,884 -9,552 | -12% | -$361K |
|
|
MYOV
11
DELISTED
Myovant Sciences Ltd.
MYOV
| $2.67M | 1.88% | 111,925 -12,226 | -10% | -$292K |
|
|
RARX
12
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $2.67M | 1.87% | 118,959 -30,149 | -20% | -$675K |
|
13
Travere Therapeutics
TVTX
$1.56B
| $2.5M | 1.76% | 110,627 +17,687 | +19% | +$400K |
|
14
Neurocrine Biosciences
NBIX
$13.8B
| $2.49M | 1.75% | 28,287 +2,998 | +12% | +$264K |
|
|
ALXN
15
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $2.49M | 1.75% | 18,429 -1,238 | -6% | -$167K |
|
16
Wave Life Sciences
WVE
$1.53B
| $2.46M | 1.73% | 63,434 +5,207 | +9% | +$202K |
|
17
Incyte
INCY
$16.5B
| $2.45M | 1.72% | 28,518 -7,153 | -20% | -$615K |
|
|
SGEN
18
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.44M | 1.72% | 33,368 -8,171 | -20% | -$598K |
|
|
THOR
19
DELISTED
Synthorx, Inc. Common Stock
THOR
| $2.44M | 1.71% | +119,735 | New | +$2.44M |
|
|
GBT
20
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $2.42M | 1.7% | 45,771 -16,872 | -27% | -$893K |
|
|
ONC
21
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.38M | 1.67% | 18,039 -129 | -0.7% | -$17K |
|
|
22
argenx
ARGX
$43.6B
| $2.35M | 1.65% | +18,819 | New | +$2.35M |
|
|
ATNX
23
DELISTED
Athenex, Inc. Common Stock
ATNX
| $2.31M | 1.63% | +188,696 | New | +$2.31M |
|
24
BioMarin Pharmaceuticals
BMRN
$11.2B
| $2.25M | 1.58% | 25,376 +1,074 | +4% | +$95.4K |
|
25
Crinetics Pharmaceuticals
CRNX
$2.92B
| $2.21M | 1.55% | 97,035 +11,091 | +13% | +$252K |
|